» Articles » PMID: 39939531

Associations of Subclinical Microcalcification and Inflammation with Carotid Atheroma Development: a Dual-tracer PET/CT Study

Abstract

Purpose: Carotid artery atherosclerosis, a significant manifestation of cardiovascular disease (CVD) and leading cause of stroke, develops through a gradual process of arterial inflammation and calcification. This study explores the relationship between arterial inflammation (18 F-FDG PET/CT) and vascular calcification (18 F-NaF PET/CT) in the left and right common carotid arteries (LCC/RCC) and their association with CVD and thromboembolic risk in patients with subclinical atherosclerosis.

Methods: A cohort of 115 subjects (73 healthy volunteers, 42 at-risk for CVD) underwent 18 F-NaF and 18 F-FDG PET/CT imaging. Radiotracer uptake was quantitatively assessed by measuring the average blood-pool-corrected mean standardized uptake value (aSUVmean).

Results: Relative to healthy volunteers, at-risk subjects had greater uptake of NaF and FDG (10-22% and 16-27% higher, respectively, in both arteries, p < 0.05). On multivariate regression, NaF aSUVmean correlated with age and BMI (p < 0.01), and FDG aSUVmean correlated with BMI (p ≤ 0.01), fibrinogen (p < 0.01 in LCC only), and total cholesterol (p = 0.02 in RCC only). NaF aSUVmean increased with elevated 10-year CVD risk (p = 0.003 in LCC only), while no significant trend was seen for FDG. NaF and FDG aSUVmean increased with elevated thromboembolic risk in both arteries (p < 0.05). No correlations between NaF and FDG aSUVmean were observed (p > 0.05).

Conclusion: 18 F-NaF PET/CT may serve as a prognostic tool for carotid microcalcification and subclinical atherosclerosis, while the utility of 18 F-FDG PET/CT remains uncertain.

Clinical Trial Registration: "Cardiovascular Molecular Calcification Assessed by 18F-NaF PET CT (CAMONA)", NCT01724749, https://clinicaltrials.gov/study/NCT01724749 .

Citing Articles

F-FDG PET/CT metabolic parameter changes to assess vascular inflammatory response in patients with diffuse large B-cell lymphoma.

Xie W, Cao L, Yu J, Tian A, Wang J, Lin R BMC Med Imaging. 2025; 25(1):81.

PMID: 40055673 PMC: 11889901. DOI: 10.1186/s12880-025-01617-0.

References
1.
Jebari-Benslaiman S, Galicia-Garcia U, Larrea-Sebal A, Olaetxea J, Alloza I, Vandenbroeck K . Pathophysiology of Atherosclerosis. Int J Mol Sci. 2022; 23(6). PMC: 8954705. DOI: 10.3390/ijms23063346. View

2.
Gimbrone Jr M, Garcia-Cardena G . Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res. 2016; 118(4):620-36. PMC: 4762052. DOI: 10.1161/CIRCRESAHA.115.306301. View

3.
Moore K, Tabas I . Macrophages in the pathogenesis of atherosclerosis. Cell. 2011; 145(3):341-55. PMC: 3111065. DOI: 10.1016/j.cell.2011.04.005. View

4.
Voros S, Rinehart S, Qian Z, Joshi P, Vazquez G, Fischer C . Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis. JACC Cardiovasc Imaging. 2011; 4(5):537-48. DOI: 10.1016/j.jcmg.2011.03.006. View

5.
Steinl D, Kaufmann B . Ultrasound imaging for risk assessment in atherosclerosis. Int J Mol Sci. 2015; 16(5):9749-69. PMC: 4463615. DOI: 10.3390/ijms16059749. View